Mitchell Kapoor
Analyst, HC Wainwright
Replay available
Rain Enhancement Technologies Holdco, Inc. (RAIN) Q3 2022 Earnings Call
Rain Enhancement Technologies Holdco, Inc. (NASDAQ: RAIN) Q3 2022 earnings conference call, held 2022-11-10. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Michael Schmidt
Analyst, Guggenheim
Avinash Valanki
Chief Executive Officer
Nelson Cabotuan
SVP of Finance
Richard Bryce
Chief Medical Officer
Robert Doble
Chief Scientific Officer
Dan Ferry
Host, LifeSci Advisors
Jeff Jones
Analyst, Oppenheimer & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Rain Enhancement Technologies Holdco, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.073 Greetings and welcome to the RAIN Therapeutics Third Quarter Earnings Conference Call. 00:00:05.073 -- 00:00:09.136 At this time, all participants are in a listen-only mode. 00:00:09.136 -- 00:00:13.099 A brief question and answer session will follow the formal presentation. 00:00:13.099 -- 00:00:17.262 If anyone should require operator assistance during the conference, please press star 00:00:17.262 -- 00:00:22.386 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:22.386 -- 00:00:26.549 It is now my pleasure to introduce your host, Dan Ferry with LifeSci Advisors. 00:00:26.549 -- 00:00:29.030 Please go ahead. 00:00:29.091 -- 00:00:32.206 Thank you, Operator. and good afternoon. 00:00:32.206 -- 00:00:37.749 With me today on the phone are Avinish Valanki, Chief Executive Officer of RAIN Therapeutics, 00:00:37.749 -- 00:00:41.271 Robert Doble, Chief Scientific Officer, 00:00:41.271 -- 00:00:46.915 Richard Bryce, Chief Medical Officer, and Nelson Cabotuan, SVP 00:00:46.915 -- 00:00:52.438 of Finance. During today's call, Avinish will provide an overall business update. 00:00:52.438 -- 00:00:55.319 Bob will review the interim Mantra 2 data. 00:00:55.319 -- 00:00:58.706 Richard will provide an update on RAIN's clinical programs. 00:00:58.706 -- 00:01:02.027 and Nelson will review the financials. 00:01:02.288 -- 00:01:06.071 Before we begin, I would like to remind you that statements made during this conference 00:01:06.071 -- 00:01:10.874 call that are not historical facts are forward-looking statements within the meaning 00:01:10.874 -- 00:01:13.096 of the Private Securities Litigation Reform Act of 1995. 00:01:13.096 -- 00:01:15.017 These 00:01:15.017 -- 00:01:19.180 forward-looking statements are ...